AllianceBernstein’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Buy
20,572
+11,310
+122% +$1.13M ﹤0.01% 2008
2025
Q4
$901K Hold
9,262
﹤0.01% 2390
2025
Q3
$659K Hold
9,262
﹤0.01% 2540
2025
Q2
$554K Sell
9,262
-1,000
-10% -$54.8K ﹤0.01% 2579
2025
Q1
$539K Sell
10,262
-370
-3% -$20.8K ﹤0.01% 2523
2024
Q4
$585K Sell
10,632
-698
-6% -$36.7K ﹤0.01% 2566
2024
Q3
$570K Hold
11,330
﹤0.01% 2601
2024
Q2
$498K Buy
11,330
+450
+4% +$19.1K ﹤0.01% 2671
2024
Q1
$479K Sell
10,880
-460
-4% -$20.3K ﹤0.01% 2600
2023
Q4
$538K Sell
11,340
-1,250
-10% -$52.5K ﹤0.01% 2572
2023
Q3
$559K Sell
12,590
-400
-3% -$18.6K ﹤0.01% 2517
2023
Q2
$620K Sell
12,990
-310
-2% -$14K ﹤0.01% 2520
2023
Q1
$523K Hold
13,300
﹤0.01% 2550
2022
Q4
$376K Buy
13,300
+600
+5% +$17.2K ﹤0.01% 2780
2022
Q3
$382K Hold
12,700
﹤0.01% 2764
2022
Q2
$431K Buy
12,700
+400
+3% +$14.3K ﹤0.01% 2740
2022
Q1
$552K Hold
12,300
﹤0.01% 2632
2021
Q4
$568K Hold
12,300
﹤0.01% 2679
2021
Q3
$413K Hold
12,300
﹤0.01% 2832
2021
Q2
$362K Buy
12,300
+200
+2% +$5.51K ﹤0.01% 2952
2021
Q1
$312K Hold
12,100
﹤0.01% 2888
2020
Q4
$276K Hold
12,100
﹤0.01% 2894
2020
Q3
$259K Sell
12,100
-1,400
-10% -$31.4K ﹤0.01% 2870
2020
Q2
$313K Buy
13,500
+3,600
+36% +$77.3K ﹤0.01% 2858
2020
Q1
$211K Buy
+9,900
New +$236K ﹤0.01% 2782

Other funds holding IRMD

AllianceBernstein's IRMD Position: Q1 2026 in Review

AllianceBernstein increased its iRadimed (IRMD) stake by 122% in Q1 2026, buying an estimated $1.13M and bringing the position to 20,572 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

AllianceBernstein first reported a position in IRMD in Q1 2020 and has held it in 25 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • AllianceBernstein held 20,572 shares of iRadimed worth $2M as of Q1 2026.
  • AllianceBernstein bought 11,310 iRadimed shares in Q1 2026, an estimated $1.13M.
  • iRadimed made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2008 holding.
  • AllianceBernstein first reported a position in iRadimed in Q1 2020 and has held it in 25 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.